Figure 9.
Differential putative chemotherapeutic response to subtypes. (A) The box plots of the estimated IC50 for Sorafenib in subtypes. (B) The box plots of the estimated IC50 for Sunitinib in subtypes.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.